Stockscreener 앱 받기
10.98
3.00%
-0.34
시간 외 거래:
10.77
-0.21
-1.91%
전일 마감가:
$11.32
열려 있는:
$11.36
하루 거래량:
34,694
Relative Volume:
0.25
시가총액:
$169.72M
수익:
$54,000
순이익/손실:
$-210.26M
주가수익비율:
-13.90
EPS:
-0.79
순현금흐름:
$-159.01M
1주 성능:
-0.36%
1개월 성능:
+17.62%
6개월 성능:
-4.29%
1년 성능:
-63.40%
1일 변동 폭
$10.82
$12.00
1주일 범위
$10.82
$12.08
52주 변동 폭
$7.65
$32.40
Lyell Immunopharma Inc Stock (LYEL) Company Profile
명칭
Lyell Immunopharma Inc
전화
650 695-0677
주소
201 HASKINS WAY, SOUTH SAN FRANCISCO
LYEL을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
LYEL
Lyell Immunopharma Inc
|
10.98 | 212.86M | 54,000 | -210.26M | -159.01M | -0.79 |
|
VRTX
Vertex Pharmaceuticals Inc
|
366.54 | 98.88B | 11.42B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
563.00 | 58.84B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
438.93 | 56.12B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
661.83 | 41.20B | 3.05B | 1.28B | -614.78M | 19.58 |
|
ONC
Beone Medicines Ltd Adr
|
288.18 | 35.49B | 3.81B | -644.79M | -669.77M | -6.24 |
Lyell Immunopharma Inc Stock (LYEL) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2024-10-30 | 다운그레이드 | BofA Securities | Buy → Underperform |
| 2024-06-27 | 다운그레이드 | H.C. Wainwright | Buy → Neutral |
| 2023-08-28 | 다운그레이드 | JP Morgan | Overweight → Neutral |
| 2022-11-14 | 다운그레이드 | Morgan Stanley | Overweight → Equal-Weight |
| 2022-11-11 | 다운그레이드 | Goldman | Buy → Neutral |
| 2022-10-17 | 개시 | H.C. Wainwright | Buy |
| 2021-07-12 | 개시 | BofA Securities | Buy |
| 2021-07-12 | 개시 | Goldman | Buy |
| 2021-07-12 | 개시 | JP Morgan | Overweight |
| 2021-07-12 | 개시 | Morgan Stanley | Overweight |
모두보기
Lyell Immunopharma Inc 주식(LYEL)의 최신 뉴스
What’s next for Lyell Immunopharma Inc. stock priceReversal Pattern Insights with Entry Tips - Newser
Applying big data sentiment scoring on Lyell Immunopharma Inc.Free Trade Insight With Community Collaboration - Newser
Can you recover from losses in Lyell Immunopharma Inc.Free Short Term Buy Zone Stock Alerts - Newser
Will earnings trigger a reversal in Lyell Immunopharma Inc.Free Breakout Entry Signal Confirmation Tool - Newser
Published on: 2025-08-09 23:30:02 - Newser
What technical models suggest about Lyell Immunopharma Inc.’s comebackGrowth Projection Summary for Long-Term Investors - Newser
Regression analysis insights on Lyell Immunopharma Inc. performanceFree Community Entry Consensus Trade Ideas - Newser
Visual trend scoring systems applied to Lyell Immunopharma Inc.Daily Trade Setup Forecast with Confidence - Newser
Will Lyell Immunopharma Inc. rebound enough to break evenAI Pattern Recognition and Trade Prediction - Newser
Custom strategy builders for tracking Lyell Immunopharma Inc.Buy Candidate Summary Based on Fundamentals - Newser
How to use a screener to detect Lyell Immunopharma Inc. breakoutsHistorical Market Behavior and Trend Summary - Newser
Intraday pattern recognizer results for Lyell Immunopharma Inc.AI-Based Signal Detection for Active Traders - Newser
Analyzing drawdowns of Lyell Immunopharma Inc. with statistical toolsSwing Trade Signal and Price Prediction - Newser
Analyzing recovery setups for Lyell Immunopharma Inc. investorsDownside Risk Evaluation and Stock Analysis - Newser
Should you wait for a breakout in Lyell Immunopharma Inc.Forecasting Stock Moves with AI Insights - Newser
What makes Lyell Immunopharma Inc. stock price move sharplyBuild a strong portfolio for growth and safety - Jammu Links News
Lyell Immunopharma Inc. Stock Analysis and ForecastUnlock exclusive stock market forecasts - Jammu Links News
When is Lyell Immunopharma Inc. stock expected to show significant growthSuperior trading gains - Jammu Links News
What institutional investors are buying Lyell Immunopharma Inc. stockBuild a diversified portfolio for risk mitigation - Jammu Links News
Should I hold or sell Lyell Immunopharma Inc. stock in 2025Outstanding trading profits - Jammu Links News
Does Lyell Immunopharma Inc. stock perform well during market downturnsUnlock powerful market insights for success - Jammu Links News
How strong is Lyell Immunopharma Inc. company’s balance sheetInvest smarter with data-backed trading alerts - Jammu Links News
What catalysts could drive Lyell Immunopharma Inc. stock higher in 2025Get expert alerts on market-moving stocks - Jammu Links News
Why Lyell Immunopharma Inc. stock attracts strong analyst attentionSecure Buy Strategy Based on Risk Parameters - Newser
Is Lyell Immunopharma Inc. a growth stock or a value stockStock Market Picks With High Returns - jammulinksnews.com
Does Lyell Immunopharma Inc. show high probability of reboundPortfolio Positioning Strategy With Timing - Newser
Detecting price anomalies in Lyell Immunopharma Inc. with AIFree Weekly Chart Analysis With Entry Advice - Newser
Live Chart Scan Detects Wedge Pattern in Lyell Immunopharma Inc.Entry and Exit Strategy Optimizer Tool Tested - metal.it
Biotech Underdogs Line Up for Pivotal Shots at Game-Changing Cancer Treatments - The Community Press
Lyell Immunopharma Inc (LYEL) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.24%
3.39%
자본화:
|
볼륨(24시간):